Is ‘AKIDO’ Japanese for the Greek word ‘AKIDA’.
At least they did not use ‘Braino’ chip.
But no doubt compared with that other rag they did a sterling job.
The one observation I would make is how easy it is to keep things a secret from market analysts.
On 23 December, 2020 Brainchip announced the signing of the unconditional IP licence agreement with Renesas (No. 3 supplier to Automotive Industry) and then by not mentioning Renesas (by name) again despite confirming in January 4C that revenue was received from the IP licence industry analysts have been fooled into believing the only possible income will come via the sale of AKD1000 chips.
This is despite the fact that Brainchip has stated time and time again they are pursuing an IP licensing model.
If Brainchip had run this cunning plan by me at the start I would have said no way it will never work. I might even have asked if they were fans of Baldrick from Blackadder. But it has worked, so good thing they did not ask me.
My opinion only DYOR
FF.
AKIDA Ballista
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-7741
-
-
- There are more pages in this discussion • 25,840 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
0.005(1.79%) |
Mkt cap ! $572.0M |
Open | High | Low | Value | Volume |
27.5¢ | 30.0¢ | 27.0¢ | $3.976M | 13.85M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 64649 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 528318 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 49343 | 0.285 |
33 | 1962783 | 0.280 |
32 | 1431938 | 0.275 |
53 | 1519446 | 0.270 |
13 | 498170 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 525498 | 11 |
0.295 | 541665 | 15 |
0.300 | 2047535 | 63 |
0.305 | 815845 | 27 |
0.310 | 1862519 | 32 |
Last trade - 12.19pm 13/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online